About this episode

The episode discusses emerging immunotherapies for solid tumors with experts in the field.

Guest: This special episode was recorded in front of a live audience at IMMUNOLOGY2026 in Boston. Brenda and Jason sit down with Dr. Charles Sentman, Director of the Center for Synthetic Immunity at Dartmouth College, and Dr. Giulia Escobar, Director of Pre-Clinical Research at Massachusetts General Hospital, to explore new strategies aimed at overcoming the unique challenges of treating solid tumors. They focus on real-world challenges in CAR T and NK cell therapies, including barriers to treating solid tumors, manufacturing and accessibility hurdles, and emerging applications beyond oncology, such as autoimmunity and neurodegenerative disease. Featured Products and Resources: Stay up-to-date with the latest in human immunology news. Download a free wallchart on the production of CAR T cells. Image courtesy of [Drs. Charles Sentman and Giulia Escobar] Subscribe to our newsletter! Never miss updates about new episodes. Subscribe

More episodes of The Immunology Podcast

• Ep. 131: “Lymphocyte Development” Featuring Dr. Alfred Singer · May 5, 2026 · 1h 11m
• IMMUNOLOGY2026™: Day 5 · April 20, 2026 · 18 min
• IMMUNOLOGY2026™: Day 4 · April 19, 2026 · 16 min
• IMMUNOLOGY2026™: Day 3 · April 18, 2026 · 24 min
• IMMUNOLOGY2026™: Day 2 · April 17, 2026 · 27 min
• IMMUNOLOGY2026™: Day 1 · April 16, 2026 · 18 min

Explore listener stats, chart rankings, contacts and more on the The Immunology Podcast podcast page.